StockTipsArenaBeta

BUY Divi's Laboratories Limited — Ashish Bahety, Profitmart Securities

BUYDivi's Laboratories Limited
Divi's Laboratories share price target & all analyst calls

byAshish Bahety, Profitmart SecuritiesHorizon: NA (inferred Intraday)22 Oct 2026, 9:50 am ISTvia CNBC Awaaz.

Entry₹9,150Inferred
Target₹9,350
Total upside +2.19%
Stop loss₹9,060-0.98% risk
CMP₹9,131Just now
Active-0.21%+2.40%upside left 2h left
Follow Ashish Bahety for new calls(14% target hit, 227 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 14 other Intraday picks this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 1:04 pm IST
2 supporting1 opposing
Supports the BUY call (2)

Divi's Laboratories shares gain as weight loss drug receives EU panel backing

NewsCnbc-Tv18·19 Oct · 3d ago

(opens in new tab)

Divi's Laboratories shares in focus as weight loss drug receives EU panel backing

NewsCnbc-Tv18·19 Oct · 3d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

1 advisor has an active swing SELL call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·14 Oct · 1w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Divi's Laboratories

All analyst calls on Divi's Laboratories

More from Ashish Bahety, Profitmart Securities

Every call and its outcome